Insider filing · SRRK

Srinivas Akkaraju bought $1.2M of Scholar Rock Holding (SRRK)

Executed Oct 7 2025, disclosed Dec 17 2025, 70 days later, against a two-business-day limit.

Over the 21 trading sessions from the disclosed entry session (Dec 16 2025), the stock returned +4.2% (delay-adjusted); from the execution session (Oct 7 2025), -29.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

SA Srinivas Akkaraju Director profile →

Srinivas Akkaraju (Director) filed 12 Form 4 reports in the trailing twelve months (12 purchases, 1 sale, 2 filed past the two-business-day deadline; 1 filing reported both), most often in Alumis Inc. (ALMS). Across 11 priced purchase filings, the average 21-session return was +35.0% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $11.9M of SRRK (287,970 sh across 4 lots, as filed), executed Oct 23.

SRRK Scholar Rock Holding Corporation SRRK · Healthcare · 58 filings in 24 months ticker →

Healthcare · Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular a…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→